Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.
In an experimental trial, a personalized mRNA vaccine was tested in 14 individuals with an aggressive form of breast cancer. It trained immune cells to target cancer-specific mutant proteins, inducing ...
News-Medical.Net on MSN
Precision mRNA vaccine strategy shows early promise for improving TNBC relapse risk
By Vijay Kumar Malesu A pioneering personalized mRNA vaccine study reveals lasting immune responses in triple-negative breast cancer, offering early signals that tailored cancer vaccination may help ...
The study involved 550 healthy U.S. adults ages 18 to 75 who received either the experimental combo vaccine and a placebo or ...
4don MSN
Wednesday's Daily Dose: A new mRNA flu vaccine, robotic surgery milestone and lung cancer screening
From a potential new flu vaccine to a groundbreaking surgical first and critical health reminders, here's today's essential health news.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results